Impact of Clinical Pharmacist Intervention on the Management of Health Related Quality of Life in Chronic Obstructive Pulmonary Disease

Authors

  • Sai Sravanthi Rompicharla Intern, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bangalore, India
  • Ann Mary Swaroop Assistant Professor, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bangalore, India

Keywords:

COPD, HRQL, medication adherence, MGL, SF-36, clinical pharmacist

Abstract

Background: Patient adherence to treatment in chronic obstructive pulmonary disease is essential to optimize disease management. Health-related quality of life is an important domain for measuring the impact of chronic disease. Objectives: The main objective of our study is to assess the health related quality of life and medication adherence: pre and post clinical pharmacist intervention. Setting: Respiratory Medicine Department of M.S. Ramaiah Hospitals, Bengaluru. Methods: A prospective interventional study was conducted. 96 subjects were recruited in the study based on inclusion criteria. Adherence to the treatment was assessed through Morisky-Greene-Levine scale. The health-related quality of life was assessed through SF-36. Reassessment of the above was conducted after 1-year span and the result was compared, evaluated and measured with appropriate statistics. Results: Participants in the high adherence category are 12.5% in the pre-counselling and 56.25% post-counselling. Highest correlation among SF-36 and Morisky-Greene-Levine scale was observed between pain and adherence (0.354). The level of p<0.05 was considered as significant. Conclusion: Medication adherence plays a key role in health-related quality of life in chronic obstructive pulmonary disease subjects. Statistically, significant improvement was observed in physical, general and social and emotional parameters.

Downloads

Download data is not yet available.

Downloads

Published

03-09-2021

Issue

Section

Articles

How to Cite

[1]
S. S. Rompicharla and A. M. Swaroop, “Impact of Clinical Pharmacist Intervention on the Management of Health Related Quality of Life in Chronic Obstructive Pulmonary Disease”, IJRESM, vol. 4, no. 8, pp. 327–332, Sep. 2021, Accessed: May 27, 2024. [Online]. Available: https://journal.ijresm.com/index.php/ijresm/article/view/1272